Tag Archives: SGMO

Shares of Spark Therapeutics (NASDAQ:ONCE) have seen a nice bounce recently, having risen by 30% since late February. It looks like my “buy the dip” piece in late November was followed by a much larger “dip” than I was expecting (Note: This was an unexpected event and great example of how biotech is a minefield).

Avisol Capital Partners, managed by Drs Udaya Maiya and Ashok Dutta, is writing a daily scoop of all sorts of news, catalysts, ratings, and other actionable details for its watch list stocks (and the rest of the healthcare universe). The watch list is available to Total Pharma Tracker subscribers. Some sections, like the catalyst data, abstract selections, AdComm coverages, Buy/Sell summaries....More>>>

Avisol Capital Partners, managed by Drs Udaya Maiya and Ashok Dutta, is writing a daily scoop of all sorts of news, catalysts, ratings, and other actionable details for its watch list stocks (and the rest of the healthcare universe). The watch list is available to Total Pharma Tracker subscribers. Some sections, like the catalyst data, abstract selections, AdComm coverages, Buy/Sell summaries....More>>>

Accenture (NYSE:ACN) is a global technology consulting company that has been in the news a lot over the last month. On March 23, 2017, the company released its Q2 2017 results and revised full-year 2017 guidance, which were widely viewed as "disappointments" by the financial community. In Ap

Valeant Pharmaceuticals (NYSE:VRX) is by no means a healthy company. Investing in them is by no means for the faint of heart. Since hitting highs of $259.98 on August 4th, 2015, VRX has been a deathtrap for investors, losing 95% of its market value. There are many reasons for that decline, but I

Small cap RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) is focused on regenerative medicine - a game-changing area of medicine with the potential to fully heal damaged tissues and organs. According to Wikipedia, the term wasfirst used in a 1992 article on hospital administration by Leland Kaiser